To determine whether a period of starvation (nil by mouth) after gastrointestinal surgery is beneficial.
Data extraction
The data were extracted independently by two authors, checked for consistency by another author, and sent to the trialists for review. Several categories of data were extracted: the number of patients; site of surgery (pancreatic, hepatobiliary, upper gastrointestinal or lower gastrointestinal); whether an intestinal anastomosis was formed; whether the pathology was benign or malignant; the type of feed used; the method of administering the feed; and the unplanned reinsertion of a nasogastric tube.
Methods of synthesis
How were the studies combined? The results from individual studies were combined using the relative risk (RR) and a fixed-effect meta-analysis. Data on the length of hospital stay were pooled using non-standardised mean differences. Funnel plots were used to determine the presence of publication bias and related biases, and a statistical test of funnel plot asymmetry was performed.
How were differences between studies investigated?
A chi-squared test was used to test the homogeneity of the RRs. A sensitivity analysis, in which data from patients who did not have an intestinal anastomosis were excluded, was performed. A subgroup analysis investigated whether the risk of anastomotic dehiscence differed according to whether the anastomosis was proximal or distal to the site of feeding.
Results of the review
Eleven RCTs involving 929 participants (463 early enteral feeding and 466 nil by mouth) were included.
Methodological quality: the reporting on concealment of allocation and blinding was poor. Three trials took steps to conceal allocation and only one trial reported a blind outcome assessment.
Funnel plots: these showed no clear evidence of asymmetry for any outcome (p>0.10 by regression test), except for mortality (p=0.068).
Anastomotic dehiscence (8 studies): the absolute risks ranged from 2 to 7% in the early feeding groups and from 1 to 25% in the control groups. The combined RR was 0.53 (95% confidence interval, CI: 0.26, 1.08, p=0.080) and although this indicated a risk reduction, it did not show a statistically-significant reduction in the risk of anastomotic dehiscence with early feeding. There was no evidence of heterogeneity between the trials (chi-squared 2.10, p=0.96). The results were similar when patients without anastomosis were excluded (RR 0.54, 95% CI: 0.26, 1.09).
Any infection (9 trials): the absolute risks ranged from 3 to 30% in the early feeding groups and from 5 to 47% in the control groups. The combined RR was 0.72 (95% CI: 0.54, 0.98, p=0.036), indicating a significant reduction in the risk of infection with early feeding. There was little evidence of heterogeneity between the trials (chi-squared 10.7, p=0.22).
Vomiting (6 trials): the absolute risks ranged from 21 to 50% in the early feeding groups and from 14 to 57% in the control groups. The combined RR was 1.27 (95% CI: 1.01, 1.61, p=0.045), indicating a significant increase in the risk of vomiting with early feeding. When nasogastric tubes were not placed routinely at the time of surgery, the rate of placement because of nausea and vomiting was higher in patients fed early (RR 1.21, 95% CI: 0.73, 1.99, p=0.46).
Length of hospital stay (11 trials): the mean length of stay ranged from 6.2 to 14.0 days in the early feeding groups and from 6.8 to 19.0 days in the control groups. The combined difference in means was 0.84 days (95% CI: 0.36, 1.33, p=0.001), indicating a statistically-significant reduction of about one day in the mean length of stay in hospital with early feeding. There was some evidence of heterogeneity between the trials (chi-squared 16.2, p=0.094). The results were similar when two trials with incomplete data were excluded.
Risk reductions with early feeding were also seen for wound infection (6 trials), pneumonia (7 trials), intra-abdominal abscess (5 trials) and mortality (5 trials), but these failed to reach statistical significance (p>0.10).
Two major complications of feeding were reported in the same trial in patients fed via jejunostomies.
